Dorian LPG
LPG
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
eBay
EBAY
Lantheus
LNTH
US Stock MarketDetailed Quotes
APGE Apogee Therapeutics
- 44.690
- -3.400-7.07%
Close Dec 18 16:00 ET
- 43.710
- -0.980-2.19%
Pre 06:28 ET
2.61BMarket Cap-17.34P/E (TTM)
48.850High43.690Low511.17KVolume48.240Open48.090Pre Close23.54MTurnover1.76%Turnover RatioLossP/E (Static)58.51MShares72.29052wk High3.56P/B1.30BFloat Cap27.05052wk Low--Dividend TTM29.10MShs Float72.290Historical High--Div YieldTTM10.73%Amplitude14.190Historical Low46.044Avg Price1Lot Size
About Apogee Therapeutics Company
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.
Company Profile
SymbolAPGE
Company NameApogee Therapeutics
Listing DateJul 14, 2023
Issue Price17.00
Founded2022
CEODr. Michael Henderson, M.D.
MarketNASDAQ
Employees91
Fiscal Year Ends12-31
Address221 Crescent Street,Building 17, Suite 102b
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-650-394-5230
Company Executives
- Name
- Position
- Salary
- Dr. Michael Henderson, M.D.
- Chief Executive Officer and Director
- 1.17M
- Dr. Carl Dambkowski, M.D.
- Chief Medical Officer
- 870.83K
- Jane Pritchett Henderson
- Chief Financial Officer and Chief Accounting Officer
- 1.72M
- Mark C. McKenna
- Chairman of the Board
- 972.87K
- Dr. Lisa L. Bollinger, M.D.
- Director
- --
- Dr. Andrew Gottesdiener, M.D.
- Independent Director
- 666.57K
- Jennifer A. Fox
- Independent Director
- 414.57K
- Tomas Kiselak
- Independent Director
- 662.82K
- Peter Harwin
- Independent Director
- 668.57K
- William B.J. Jones, Jr
- Independent Director
- 411.66K
- Nimish Shah
- Independent Director
- 664.82K